|
|
Blood, 1 July 2004, Vol. 104, No. 1, pp. 43-50.
Prepublished online as a Blood First Edition Paper on March 11, 2004; DOI 10.1182/blood-2003-07-2240.
Previous Article | Next Article 
Submitted July 9, 2003
Accepted February 13, 2004
Superoxide Dismutase-3 Promotes Full Expression of the Erythropoietin Response to Hypoxia
Hagir B Suliman, Mervat Ali, and Claude A Piantadosi*
Medicine, Duke University, Durham, NC, USA; Anesthesiology, Duke University, Durham, NC, USA
Anesthesiology, Duke University, Durham, NC, USA
* Corresponding author; email: piant001{at}mc.duke.edu.
Extracellular superoxide dismutase (SOD3) is the primary extracellular enzymatic scavenger of superoxide (O2-). SOD3's expression is highest in kidney, but its distribution and biological functions there are unknown. To investigate the function of renal SOD3, we co-localized it with erythropoietin (EPO) to proximal tubules using in situ hybridization and immunohistochemistry. We then exposed wild type (Wt) and SOD3 knockout (KO) mice to hypoxia and found a late
hematocrit response in the KO strain. EPO mRNA expression was attenuated in KO mice during the first 6h of hypoxia preceded at 2 h by less accumulation of nuclear HIF-1 protein. Meanwhile KO mice exposed to hypoxia showed increases in renal mRNA for superoxide-producing NADPH oxidase (NOX4) and early significant increases in GSSG/GSH, a marker of oxidative stress, compared to Wt mice. Plasma nitrite/nitrate and renal 3-nitrotyrosine (3-NTyr), indicating peroxynitrite formation, increased later in hypoxia, and renal endothelial nitric oxide synthase
protein induction was similar in both strains. These data show that hypoxic activation of HIF-1 and its target gene EPO in mouse kidney is regulated closely by the oxidant/antioxidant equilibrium involving SOD3, thus identifying renal SOD3 as a regulatory element in the body's innate adaptation to hypoxia.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Ganguly, M. Depner, C. Fattman, K. Bein, T. D. Oury, S. C. Wesselkamper, M. T. Borchers, M. Schreiber, F. Gao, E. von Mutius, et al.
Superoxide dismutase 3, extracellular (SOD3) variants and lung function
Physiol Genomics,
May 13, 2009;
37(3):
260 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Physiol Rev,
January 1, 2009;
89(1):
27 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Nozik-Grayck, H. B. Suliman, S. Majka, J. Albietz, Z. Van Rheen, K. Roush, and K. R. Stenmark
Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling
Am J Physiol Lung Cell Mol Physiol,
September 1, 2008;
295(3):
L422 - L430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev,
January 1, 2007;
87(1):
245 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Am J Physiol Renal Physiol,
November 1, 2006;
291(5):
F932 - F944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, P. S. Gill, and W. J. Welch
Oxygen availability limits renal NADPH-dependent superoxide production
Am J Physiol Renal Physiol,
October 1, 2005;
289(4):
F749 - F753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Geiszt and T. L. Leto
The Nox Family of NAD(P)H Oxidases: Host Defense and Beyond
J. Biol. Chem.,
December 10, 2004;
279(50):
51715 - 51718.
[Full Text]
[PDF]
|
 |
|
|
|